Seaport Therapeutics Inc. Common Stock

SPTX | NASDAQ

Price Alert Chart Builder DCF Calculator

$19.35

-$0.25 (-1.28%)

Nov 2, 2026, 9:47 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $1.04B

Enterprise Value $780.91M

Beta 1.13

Average Volume 189.31K

Shares Outstanding (Diluted) 53.53M

Shares Change YoY N/A

Institutional Ownership 70.19%

Exchange NASDAQ

ISIN US81221K1088

Price Performance

Price Change 1M 5.0%

Price Change 3M -6.3%

Price Change 6M 13.8%

Price Change YTD N/A

Price Change 1Y N/A

Price Change 3Y N/A

Price Change 5Y N/A

1M CAGR (ann.) -8.4%

1Y CAGR (ann.) N/A

5Y CAGR (ann.) N/A

All-Time CAGR -2.4%

Valuation

PE Ratio -11.88

Forward PE N/A

PEG Ratio -0.12

Forward PEG 0.19

PS Ratio N/A

Forward PS N/A

PB Ratio 2.48

P/FCF Ratio -22.65

P/Adj. FCF Ratio -21.46

P/OCF Ratio -22.53

EV/Sales N/A

EV/EBIT -8.37

EV/EBITDA -8.43

EV/FCF -16.86

Earnings Yield -8.4%

FCF Yield -4.4%

Adj. FCF Yield -4.7%

Financial Health

Net Cash $271.7M

Total Debt $5.02M

Cash & Short-Term Investments $273.31M

Total Assets $441.68M

Current Ratio 18.00

Quick Ratio 18.00

Debt / Equity Ratio 0.01

Debt / EBITDA -0.05

Debt / FCF -0.11

OCF / Debt -9.23

Interest Coverage 0.00

Altman Z-Score 32.38

Piotroski F-Score 1

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -5.5%

Returns

Return on Assets -19.9%

Return on Equity -57.3%

Return on Invested Capital -21.8%

Return on Capital Employed -21.9%

Return on Tangible Assets -19.9%

Analyst Forecasts

Analyst Rating Buy

Analyst Count 1

EPS Growth Next 3Y -21.2%

Revenue Growth Next 3Y N/A

Earnings Date Nov 2, 2026

EPS Estimate (next Q) -$0.58

EPS Growth Est (next Q) N/A

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $38.50

Price Target Upside 96.4%

Cash Flow

Operating Cash Flow $-46.31M

Free Cash Flow $-46.31M

Adj. Free Cash Flow $-48.88M

FCF Per Share -$0.87

OCF Per Share -$0.87

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $-351K

Operating Income $-93.35M

EBITDA $-92.64M

Net Income $-88.01M

EPS (Diluted) -$1.65

Revenue / Employee N/A

Profit / Employee $-1.52M

Employees 58